Search by Drug Name
A B C D E F G H I J K L M N O P Q R S T U V W X Y ZClinical Trials for CYCLOSERINE
- iTBS+D-Cycloserine for Youth Suicide
- Innovating Shorter, All- Oral, Precised, Individualized Treatment Regimen for Rifampicin Resistant Tuberculosis：Contezolid, Delamanid and Bedaquiline Cohort
- Assisting Smokers to Switch to an e-Cigarette by Accelerating Learning of Adaptive Habits Using D-cycloserine
- D-Cycloserine+iTBS PK Study
- D-Cycloserine Augmentation of Intermittent Theta Burst Stimulation (iTBS) in Depression (COGENT)
- iTBS-DCS in Fibromyalgia
- A Study of an Oral Short-course Regimen Including Bedaquiline for the Treatment of Participants With Multidrug-resistant Tuberculosis in China
- iTBS-DCS in Obsessive Compulsive Disorder
- Repeated iTBS Cycloserine Motor Plasticity
- Uncovering Neural and Immune Mechanisms of Chronic Pain in Post Treatment Lyme Syndrome
- Evaluation of Efficacy and Safety of add-on Sarcosine in Patients With Major Depressive Disorder
- Pain, Learning, and Nocebo
- Refining MDR-TB Treatment (T) Regimens (R) for Ultra(U) Short(S) Therapy(T)-PLUS
- Randomized Controlled Multi-center Short Course Treatment for Rifampicin Resistant Tuberculosis
- D-cycloserine Augmented Treatment for Youth With Tic Disorders
- Multimodal Cue Exposure Therapy for Smoking Cessation
- The Effect of D-cycloserine on Emotional Processing
- Adjunctive D-Cycloserine in Major Depressive Disorder
- Refining MDR-TB Treatment (T) Regimens (R) for Ultra(U) Short(S) Therapy(T)
- The Effect of 18-month Regimen Containing 6 Anti-tuberculosis Drugs for Patients With MDR-TB
- AIH for Spinal Cord Repair
- NGS-Guided(G) Regimens(R) of Anti-tuberculosis(A) Drugs for the Control(C) and Eradication(E) of MDR-TB
- D-cycloserine for the Treatment of Chronic, Refractory Low Back Pain
- Cycloserine rTMS Plasticity Augmentation in Depression
- Cycloserine rTMS Plasticity Augmentation
- Project Q Pilot: Smoking Cessation for Light Smokers
- NRX101 Glx Biomarker Validation Study
- NRX101 Glx Biomarker Validation Study
- NRX100 vs. Placebo for Rapid Stabilization of Acute Suicidal Ideation and Behavior in Bipolar Depression
- NRX-101 for Maintenance of Remission From Severe Bipolar Depression in Patients With Suicidal Ideation
- NRX101 for Moderate Bipolar Depression and Suicidal Ideation
- Effect of D-cycloserine on a Short Imagery Rescripting Intervention for Subclinical PTSD
- Mineralocorticoid Receptor, NMDA Receptor and Cognitive Function in Depression
- D-cycloserine: A Novel Treatment for Gulf War Illness (GWDCS)
- Sequential Therapy for the Treatment of Severe Bipolar Depression.
- D-Cycloserine and Virtual Reality Exposure Therapy
- D-cycloserine for Relapse Prevention Following Intravenous Ketamine in Treatment-resistant Depression
- Glutamate, Learning, and Working Memory
- Cycloserine in the Treatment of Sleep Apnea
- Uncovering Neural and Immune Mechanisms of Chronic Pain in Post Treatment Lyme Syndrome
- Translational Approach to the Understanding and Treatment of Obsessive-Compulsive Disorder (OCD). Can D-Cycloserine Enhance and Stabilize the Treatment-response in Relapsed and Non-responding OCD-patients?
- Lower Limb Function After Spinal Cord Injury
- Augmentation of Brief Habit Reversal Training With D-cycloserine or Placebo
- An Open-label RCT to Evaluate a New Treatment Regimen for Patients With Multi-drug Resistant Tuberculosis
- Treating Urological Chronic Pelvic Pain Syndrome (UCPPS) Pain
- Improving Therapeutic Learning in Depression: Proof of Concept
- Augmentation of Cognitive Training in Children With TBI With D-Cyloserine
- Targeting a Genetic Mutation in Glycine Metabolism With D-cycloserine
- Clinical Trial to Investigate the Pharmacokinetics of Second-Line Anti-Tuberculosis Agents
- Medication Enhanced Rapid Therapy
- Patients Response to Early Switch To Oral:Osteomyelitis Study
- NMDA Receptors in Motor Learning in Humans
- Dose Timing of D-Cycloserine to Augment CBT for Social Anxiety Disorder
- A Double Blind Clinical Trial of DCS for Food Anxiety
- Understanding the Importance of Plasticity in the Brain Mechanisms of Dyspnoea Perception
- D-Cycloserine Augmentation of Cognitive Behavioral Therapy for Delusions
- Enhancing Panic and Smoking Reduction Treatment With D-Cycloserine
- Augmentation of Psychotherapy With D-Cycloserine in Agoraphobia
- D-cycloserine and Treatment of Feeding Disorders
- Effects of Nicotine Replacement Therapy and D-cycloserine on Nicotine Treatment Seekers
- D-cycloserine (DCS) Pretreatment + CBT + Nicotine Replacement Therapy for Smoking Cessation (DCS)
- NMDA Antagonists in Bipolar Depression
- The Effects of D-cycloserine on Stimulus Generalization of Conditioned Fear Healthy Controls.
- The Use of D-Cycloserine to Augment CBT for Pediatric OCD
- D-cycloserine Augmented CBT for Panic Disorder
- D-Cycloserine as an Adjunct to Internet-CBT for OCD
- Improving Learning-based Treatment of Cocaine Dependence With Medication
- Exploring Learning and Unlearning of Fear
- Developing Memory Reconsolidation Blockers as Novel Posttraumatic Stress Disorder (PTSD) Treatments
- N-methyl-D-aspartic Acid (NMDA) and Cognitive Remediation in Schizophrenia
- Exposure, D-cycloserine Enhancement, and Functional Magnetic Resonance Imaging (fMRI) in Snake Phobics
- D-cycloserine Augmentation of Cognitive Behavioral Therapy (CBT) for Pediatric Obsessive-compulsive Disorder (OCD)
- 2/2 D-Cycloserine Augmentation of CBT for Pediatric OCD
- Cognitive Remediation With D-Cycloserine
- Intravenous Ketamine in the Treatment of Obsessive-Compulsive Disorder
- D-Cycloserine to Enhance Extinction to Alcohol Cues
- The Cognitive Enhancing Effects of D-Cycloserine Among Non-Demented Elderly
- Enhancing Exposure Therapy for Post Traumatic Stress Disorder (PTSD): Virtual Reality and Imaginal Exposure With a Cognitive Enhancer
- The Effect of Single Dose D-Cycloserine on Cognitive Outcome in Moderate Traumatic Brain Injury (TBI) Patients
- D-Cycloserine Augmentation to CBT With Exposure and Response Prevention in Adults and Adolescents With OCD
- D-cycloserine Adjunctive Treatment for Posttraumatic Stress Disorder (PTSD) in Adolescents
- Effect of D-cycloserine on Treatment of Posttraumatic Stress Disorder (PTSD) in Youth
- D-Cycloserine to Enhance Cognitive Behavioral Therapy (CBT) for Acrophobia
- D-Cycloserine and Social Skills Training in Autism Spectrum Disorders
- Cognitive Enhancement and Relapse Prevention in Cocaine Addiction
- Investigation of Cycloserine as a Smoking Cessation Treatment
- D-Cycloserine-Enhancer of One-Session Treatment for Phobia of Heights
- The Influence of Glutamate on Memory in Humans
- Once Weekly D-cycloserine for Schizophrenia
- D-cycloserine Augmentation of Cognitive Remediation in Schizophrenia
- The Role of the Glutamatergic System in the Extinction of Conditioned Reinforcement Processes
- Imaginal Exposure & D-Cycloserine (DCS) for Posttraumatic Stress Disorder (PTSD)
- Transcranial Direct Current Stimulation (tDCS) Augmentation by D-Cycloserine as a Treatment for Depression
- D-Cycloserine Augmentation of Therapy for Pediatric Obsessive-Compulsive Disorder
- Virtual Reality and D-Cycloserine in Combat Related Psycological Trauma in Burn Service Members
- D-Cycloserine Augmentation of Behavior Therapy for Individuals With Body Dysmorphic Disorder
- D-Cycloserine Enhancement of Exposure-Based CBT for Smoking Cessation (DCSSmoking)
- Exposure, D-Cycloserine Enhancement, and Genetic Modulators in Panic Disorder
- D-Cycloserine and Cue Exposure in Cocaine-Dependent Individuals
- D-Cycloserine Facilitation of Cocaine - Cue Extinction
- Using D-cycloserine to Enhance the Benefits of Cognitive Behavioral Therapy for Schizophrenia
- Improving Stroke Rehabilitation: Spacing Effect and D-cycloserine
- Biomarker Study of Acamprosate in Schizophrenia
- Veteran Stress and Learning Study
- Glycine and Oral D-Cycloserine in Alcoholic Patients and Healthy Subjects
- D-Cycloserine Enhancement of Exposure in Social Phobia
- The Effect of Cycloserine on Smoking Behavior in Nicotine Dependent Smokers
- Virtual Reality & D-cycloserine (DCS) for Posttraumatic Stress Disorder (PTSD)
- Drug Discrimination in Methadone-Maintained Humans Study 1
- fMRI Study Examining Effects of D-cycloserine in Specific Phobia
- Effect of D-cycloserine Plus Cognitive Behavioral Therapy on People With Social Phobia
- Effects of Weekly Dosing of D-cycloserine on Cognitive Function in Individuals With Schizophrenia
- RCT of CBT Combined With D-Cycloserine for Treating PTSD
- Efficacy of D-Cycloserine for Enhancing the Effects of CBT for Substance Use
- D-cycloserine for Major Depressive Disorder
- A Placebo-Controlled Trial of D-Cycloserine and Exposure Therapy for Combat-PTSD
- D-cycloserine and Virtual Reality Exposure to Treat Iraq War Veterans With PTSD
- D-cycloserine in the Management of Chemotherapy-Induced Peripheral Neuropathic Pain
- D-Cycloserine Augmentation of Exposure and Response Prevention Treatment for Obsessive-Compulsive Disorder
- Adjunctive Treatment for Decreasing Symptoms of Schizophrenia
- Safety and Effectiveness of D-Cycloserine in Children With Autism
- Evaluating the Effectiveness of Aripiprazole and D-Cycloserine to Treat Symptoms Associated With Autism
- Effectiveness of D-Cycloserine as an Aid to Enhance Learning for Individuals With OCD Receiving Behavior Therapy
- Augmenting Exposure Therapy With an N-Methyl-D-Aspartate (NMDA) Agonist for Panic Disorder
- Use of an Antibiotic as an Enhancer for the Treatment of Social Phobia
- A Medication Trial Combined With Behavior Therapy for Individuals With Obsessive-compulsive Disorder
- D-cycloserine in the Management of Chronic Low Back Pain
- A Prospective Study of Multidrug Resistance and a Pilot Study of the Safety of and Clinical and Microbiologic Response to Levofloxacin in Combination With Other Antimycobacterial Drugs for Treatment of Multidrug-Resistant Pulmonary Tuberculosis (MDR
- Glycine and D-Cycloserine in Schizophrenia
- Trial of D-Cycloserine in Schizophrenia
- Neurobiology of Opioid Dependence: 3 - 3
Clinical trials list
click for details